Satoshi Morise
Hirakata, 5731010, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Zonisamide modulates cholinergic markers and alleviates levodopa-induced dyskinesia in a rat model of Parkinson's disease.
Journal: Experimental neurology
Published: April 15, 2025
A case of atezolizumab- and bevacizumab-induced myositis showing high intensity in the pterygoid muscles, soft palate, and tongue on STIR-MRI
Journal: Rinsho shinkeigaku = Clinical neurology
Published: August 30, 2023
Quantitative and Morphological Assessment of Computed Tomography-depicted Gynecomastia in Spinal and Bulbar Muscular Atrophy.
Journal: Academic radiology
Published: December 20, 2021
Zonisamide attenuates the severity of levodopa-induced dyskinesia via modulation of the striatal serotonergic system in a rat model of Parkinson's disease.
Journal: Neuropharmacology
Published: May 13, 2021
Efficacy and safety of tacrolimus as long-term monotherapy for myasthenia gravis.
Journal: Neuromuscular disorders : NMD
Published: August 20, 2020
Leptomeningeal Collaterals Strongly Correlate with Reduced Cerebrovascular Reactivity Measured by Acetazolamide-challenged Single-photon Emission Computed Tomography Using a Stereotactic Extraction Estimation Analysis in Patients with Unilateral Internal Carotid Artery Stenosis.
Journal: Internal medicine (Tokyo, Japan)
Published: September 26, 2017
Thymoma-associated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM) with Myasthenia Gravis.
Journal: Internal medicine (Tokyo, Japan)
Published: July 05, 2017
Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats.
Journal: Neuroscience research
Published: February 01, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026